Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Harbeck

Showing results (1-10 of 148) with videos related to

Pageof 15
Sort By:
Zentralblatt Fur Gynakologie|October 22, 2003
[Adjuvant chemotherapy in primary carcinoma of the breast]N Harbeck
Onkologie|January 13, 2004
[Adjuvant chemotherapy in primary breast cancer]N Harbeck
Current Medical Research and Opinion|October 29, 2008
Never too late: reducing late breast cancer relapse riskN Harbeck
Breast Cancer Research : BCR|October 13, 2001
Recent advances in technologies for the detection of occult metastatic cells in bone marrow of breast cancer patientsS Braun, N Harbeck
Expert Reviews in Molecular Medicine|October 31, 2003
Molecular markers of metastasis in breast cancer: current understanding and prospects for novel diagnosis and preventionS Braun, N Harbeck
Zentralblatt Fur Gynakologie|October 22, 2003
[u-Plasminogen activator (urinary plasminogen activator, urokinase) (uPA) and its PA-1 type 1 inhibitor are not only prognostically but also predictively significant and support clinical decisions on therapy in primary carcinoma of the breast]N Harbeck, C Thomssen
Der Internist|February 2, 2013
[Breast cancer. Individualized therapy concepts]N Harbeck, R Wuerstlein
Onkologie|November 8, 2003
Clinical relevance of prognostic factors in axillary node-negative breast cancerC Thomssen, F Jänicke, N Harbeck
Seminars in Surgical Oncology|December 18, 2001
Implications of occult metastatic cells for systemic cancer treatment in patients with breast or gastrointestinal cancerS Braun, R Rosenberg, S Thorban, et al.
Zeitschrift Fur Geburtshilfe Und Neonatologie|March 12, 2002
[Prenatal manifestation of a congenital glioblastoma - Case report]S Schindelmann, G Sandner, N Harbeck, et al.
Pageof 15

Showing results (1-10 of 148) with videos related to

Sort By:
Pageof 15
Zentralblatt Fur Gynakologie|October 22, 2003
[Adjuvant chemotherapy in primary carcinoma of the breast]N Harbeck
Onkologie|January 13, 2004
[Adjuvant chemotherapy in primary breast cancer]N Harbeck
Current Medical Research and Opinion|October 29, 2008
Never too late: reducing late breast cancer relapse riskN Harbeck
Breast Cancer Research : BCR|October 13, 2001
Recent advances in technologies for the detection of occult metastatic cells in bone marrow of breast cancer patientsS Braun, N Harbeck
Expert Reviews in Molecular Medicine|October 31, 2003
Molecular markers of metastasis in breast cancer: current understanding and prospects for novel diagnosis and preventionS Braun, N Harbeck
Zentralblatt Fur Gynakologie|October 22, 2003
[u-Plasminogen activator (urinary plasminogen activator, urokinase) (uPA) and its PA-1 type 1 inhibitor are not only prognostically but also predictively significant and support clinical decisions on therapy in primary carcinoma of the breast]N Harbeck, C Thomssen
Der Internist|February 2, 2013
[Breast cancer. Individualized therapy concepts]N Harbeck, R Wuerstlein
Onkologie|November 8, 2003
Clinical relevance of prognostic factors in axillary node-negative breast cancerC Thomssen, F Jänicke, N Harbeck
Seminars in Surgical Oncology|December 18, 2001
Implications of occult metastatic cells for systemic cancer treatment in patients with breast or gastrointestinal cancerS Braun, R Rosenberg, S Thorban, et al.
Zeitschrift Fur Geburtshilfe Und Neonatologie|March 12, 2002
[Prenatal manifestation of a congenital glioblastoma - Case report]S Schindelmann, G Sandner, N Harbeck, et al.
Pageof 15